Groundbreaking neurostimulation technology offers hope and healing for difficult-to-manage pain. Chronic low back pain, a formidable foe causing disability and soaring healthcare costs, now faces a ...

Please provide your email address to receive an email when new articles are posted on . Results published in Orthopedics showed facet joint osteoarthritis was associated with a higher multifidus ...

CLEVELAND, March 02, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced publication of clinical data evaluating the impact of ...

DUBLIN--(BUSINESS WIRE)--Mainstay Medical today announced that the United States Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth ...

The novel design of a deep muscle along the spinal column called the multifidus muscle may in fact be key to spinal support and a healthy back, according to researchers at the University of California ...

“This is a totally new way of treating back pain,” said Prentiss Lawson Jr., M.D., an associate professor in the UAB Department of Anesthesiology and Perioperative Medicine and program director of the ...

1 Department of Rehabilitation Sciences and Physical Therapy, Faculty of Medicine, Ghent University, Belgium 2 Centre of Sports Medicine, Ghent University Hospital, Belgium 3 Department of Physical ...

Background In Australian Football, hip, groin and thigh (HGT) muscle injuries have had the highest incidence and prevalence. A previous study showed that football players with relatively more severe ...

Mainstay Medical Holdings plc has won U.S. FDA approval for its Reactiv8 implantable neurostimulation device. The company is eyeing a commercial launch of the system in early 2021. The FDA approved ...